Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nautilus Biotechnolgy, Inc.

0.6518
+0.01282.00%
Post-market: 0.66480.0130+1.99%16:26 EDT
Volume:197.83K
Turnover:127.75K
Market Cap:82.33M
PE:-1.25
High:0.6862
Open:0.6363
Low:0.6200
Close:0.6390
52wk High:3.09
52wk Low:0.6200
Shares:126.31M
Float Shares:46.28M
Volume Ratio:0.77
T/O Rate:0.43%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5217
EPS(LYR):-0.5643
ROE:-31.55%
ROA:-19.30%
PB:0.45
PE(LYR):-1.16

Loading ...

Company Profile

Company Name:
Nautilus Biotechnolgy, Inc.
Exchange:
NASDAQ
Establishment Date:
2016
Employees:
128
Office Location:
2701 Eastlake Avenue East,Seattle,Washington,United States
Zip Code:
98102
Fax:
- -
Introduction:
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was incorporated in 2016 and is headquartered in Seattle, Washington.

Directors

Name
Position
Adam Stone
Chief Executive Officer and Director
Joseph Edelman
Chairman
Michael Altman
Chief Financial Officer and Director
Bradley L. Campbell
Director
Saqib Islam
Director
Todd Wider
Director

Shareholders

Name
Position
Adam Stone
Chief Executive Officer and Director
Michael Altman
Chief Financial Officer and Director
Konstantin Poukalov
Chief Business Officer